Document Type : Original Article


1 Dept. of Periodontology, Faculty of Dentistry, Urmia University of Medical Sciences, Urmia, Iran.

2 Private Practice, Urmia, Iran.


Statement of the Problem: The World Health Organization (WHO) declared severe acute respiratory syndrome coronavirus 2 a pandemic on March 11, 2020. Corona virus disease 2019 (COVID-19) is commonly transmitted from human-to-human via close contacts and touching surfaces. Reports indicated that many medical staff got infected on working with infected individuals. Likewise, dentists are at a higher risk for the virus transmission due to close proximity to patients and the nature of dental procedures. Despite all of the protections and disinfections, there were some reports of infected dentists.
Purpose: In this study, we evaluated the prevalence of infected dentists and the rate of using protection protocols by them in Iran.
Materials and Method: This survey was a cross-sectional descriptive and web-based study in which a questionnaire designed and uploaded on Google forms. The link of the form was shared among dentists in Iran via some social media groups and personal messages.
Results: A total of 945 dentists participated in this survey. A higher proportion of participants had their own private practice. About one third reported fatigue, malaise, or headaches since the COVID-19 got epidemic in Iran. Most of the respondents had provided emergency and elective dental treatments, used face shields, and surgical masks. The 26.3% of respondents were positive for COVID-19.
Conclusion: According to our analysis, about 26% of dentists had been infected with COVID -19 and most of them reported that they used the CDC’s currently recommended infection prevention and control procedures in dental offices. However, the prevalence of infection was higher than prevalence of infection in the whole population of Iran (approximately 1%) and it showed that dentists were at high risk despite using infection control and personal protection equipment (PPE).


  • Accessed May 5, 2020.
  • Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trend Micro. 2016; 24: 490-502.
  • Chen J. Pathogenicity and transmissibility of 2019-nCoV—a quick overview and comparison with other emerging viruses. Microbes 2020; 22: 69-71.
  • Khurshid Z, Asiri FYI, Al Wadaani H. Human saliva: Non-invasive fluid for detecting novel coronavirus (2019-nCoV). Int J Enviro Res Public Health. 2020; 17: 2225.
  • Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020; 12: 1-6.
  • Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Eurosurveillance. 2020; 25: 2000062.
  • Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. New England J Med. 2020; 382: 1708-1720.
  • Secon H. Nearly 3,400 Chinese healthcare workers have gotten the coronavirus and 13 have died. Business Insider. 2020. Available at: healthcare-workers-getting-coronavirus-500-infected-2020-2.
  • Zemouri C, de*Soet H, Crielaard W, Laheij A. A scoping review on bio-aerosols in healthcare and the dental environment. PloS One. 2017; 12: e0178007.
  • Volgenant C, de*Soet J. Cross-transmission in the dental office: does this make you ill? Curr Oral Health Rep. 2018; 5: 221-228.
  • Szymanska J. Dental bioaerosol as an occupational hazard in a dentist's workplace. Ann Agric Environ Med. 2007; 14: 203-237.
  • Harrel SK, Molinari J. Aerosols and splatter in dentistry: a brief review of the literature and infection control implications. J Am Dent Assoc. 2004; 135: 429-437.
  • Ching P, Harriman K, Li Y. Infection prevention and control of epidemic-and pandemic-prone acute respiratory diseases in health care : WHO interim guidelines. Geneva: WHO. 2007. p. 90.
  • Siegel JD, Rhinehart E, Jackson M, Chiarello L, Committee HCICPA. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007; 35: S65.
  • Gralton J, Tovey E, McLaws ML, Rawlinson WD. The role of particle size in aerosolised pathogen transmission: a review. J Infect. 2011; 62: 1-13.
  • Weber TP, Stilianakis NI. Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. J Infect. 2008; 57: 361-373.
  • Milton DK, Fabian MP, Cowling BJ, Grantham ML, McDevitt JJ. Influenza virus aerosols in human exhaled breath: particle size, culturability and effect of surgical masks. PLoS Pathog. 2013; 9: e1003205.
  • Tellier R. Aerosol transmission of influenza a virus: a review of new studies. Jo Royal Soc Int. 2009; 6(suppl_6): S783-S790.
  • Micik RE, Miller RL, Mazzarella MA, Ryge G. Studies on dental aerobiology: I. Bacterial aerosols generated during dental procedures. J Dent Res. 1969; 48: 49-56.
  • Miller RL, Micik RE, Abel C, Ryge G. Studies on dental aerobiology: II. Microbial splatter discharged from the oral cavity of dental patients. J Dent Res. 1971; 50: 621-625.
  • Micik RE, Miller RL, Leong AC. Studies on dental aerobiology: III. Efficacy of surgical masks in protecting dental personnel from airborne bacterial particles. J Dent Res. 1971; 50: 626-630.
  • Abel LC, Miller RL, Micik RE, Ryge G. Studies on dental aerobiology: IV. Bacterial contamination of water delivered by dental units. J Dent Res. 1971; 50: 1567-1569.
  • Miller R, Micik R. Air pollution and its control in the dental office. Dent Clin North America. 1978; 22: 453-476.
  • Hinds WC, Yifang Zhu. Aerosol technology: properties, behavior, and measurement of airborne particles. 3rd ed. Michigan: John Wiley & Sons; 1999. p. 2-8.
  • Cottone JA, Terezhalmy GT, Molinari JA. Practical Infection Control in Dentistry. Baltimore: Williams and Wilkins; 1996. p.139-140.
  • Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020; 12: 1-5.
  • Association AD. Council on Scientific Affairs and ADA Council on Dental Practice. Infection control recommendations for the dental office and the dental laboratory. J Am Dent Assoc. 1996; 127: 672-680.
  • Ge ZY, Yang LM, Xia JJ, Fu XH, Zhang YZ. Possible aerosol transmission of COVID-19 and special precautions in dentistry. J Zhejiang Univ Sci B. 2020; 21: 361-368.
  • Ather A, Patel B, Ruparel NB, Diogenes A, Hargreaves KM. Coronavirus disease 19 (COVID-19): implications for clinical dental care. J Endo. 2020; 46: 584-595.
  • Estrich CG, Mikkelsen M, Morrissey R, Geisinger ML, Ioannidou E, Vujicic M, et al. Estimating COVID-19 prevalence and infection control practices among US dentists. J Am Dent Assoc. 2020; 151: 815-824.
  • Kluytmansvan*den*Bergh MF*BA, Buiting AGM, Pas SD, Bentvelsen RG, van*den*Bijllaardt W, van*Oudheusden AJG, et al. Prevalence and clinical presentation of health care workers with symptoms of coronavirus disease 2019 in 2 Dutch hospitals during an early phase of the pandemic. JAMA Network Open. 2020; 3: e209673.
  • Lai X, Wang M, Qin C, Tan L, Ran L, Chen D, et al. Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China. JAMA Network Open. 2020; 3: e209666-e.
  • Mani NS, Budak JZ, Lan KF, Bryson-Cahn C, Zelikoff A, Barker GE, et al. Prevalence of COVID-19 infection and outcomes among symptomatic healthcare workers in Seattle, Washington. Clin Infect Dis. 2020; 71: 2702-2707.
  • Ministry of Health and Medical Education. Available at:
  • Centers for Disease and Prevention. Guidance for Dental Settings: interim infection prevention and control guidance for dental settings during the coronavirus disease (COVID-19) pandemic. Available at: https://www.cdc. gov/coronavirus / 2019-ncov/hcp/dental-settings.html.
  • Woloshin S, Patel N, Kesselheim AS. False Negative Tests for SARS-CoV-2 Infection—Challenges and Implications. New England J Med. 2020; 363: e38.